David Patience
Fortune : 1 M $ au 30/06/2026
Fortune : 1 M $ au 30/06/2026
David Patience is Chief Financial Officer at TriSalus Life Sciences, Inc. since 2025.
Previously, Chief Financial Officer at Accelerate Diagnostics, Inc. from 2023 to 2025.
Education includes an MBA from The University of Chicago Booth School of Business and an undergraduate degree from The Leeds School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 261 107 ( 0,43 % ) | 1 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TRISALUS LIFE SCIENCES, INC. | Directeur Financier/CFO | 01/07/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| ACCELERATE DIAGNOSTICS, INC. | Directeur Financier/CFO | 30/06/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
The University of Chicago Booth School of Business
The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Leeds School of Business
The Leeds School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. Medical SpecialtiesHealth Technology Engages in research, development and sales of innovative drug delivery technology & immune-oncology therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national